Daily Courier: Single Column

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Allurion Technologies, Inc. Common Stock (NY:ALUR)

0.6841 -0.0170 (-2.42%)
Official Closing Price Updated: 7:00 PM EST, Mar 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,096,582
Open 0.6800
Bid (Size) 0.6840 (100)
Ask (Size) 0.7100 (200)
Prev. Close 0.7011
Today's Range 0.6524 - 0.8280
52wk Range 0.6524 - 4.180
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Monday's session: top gainers and losers ↗
Via Chartmill
News headline image
Allurion Intends to Appeal NYSE Notice of Delisting, Execute Plan to Regain Compliance, and Expects to Continue Trading on NYSE
From Allurion Technologies, Inc.
Via Business Wire

Performance

YTD
-52.8%
-52.8%
1 Month
-44.8%
-44.8%
3 Month
-52.5%
-52.5%
6 Month
-67.4%
-67.4%
1 Year
-76.0%
-76.0%

More News

Read More
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
In today's session, these stocks are experiencing unusual volume. ↗
Via Chartmill
News headline image
Earnings Scheduled For November 12, 2025 ↗
Via Benzinga
Tuesday's session: top gainers and losers ↗
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
News headline image
Allurion Announces Exercise of Warrants for $3.0 Million in Gross Proceeds
From Allurion Technologies, Inc.
Via Business Wire
News headline image
Why Did Allurion Stock Surge Over 50% Today? ↗
Via Stocktwits
News headline image
Allurion Receives U.S. FDA Approval
From Allurion Technologies, Inc.
Via Business Wire
News headline image
Allurion Announces Partnership to Offer Combination Therapy with Mounjaro® (tirzepatide) at Discounted Prices
From Allurion Technologies, Inc.
Via Business Wire
News headline image
Allurion Announces Preliminary Fourth Quarter and Full-Year 2025 Results
From Allurion Technologies, Inc.
Via Business Wire
News headline image
Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide to Optimize Muscle Mass and GLP-1 Adherence
From Allurion Technologies, Inc.
Via Business Wire
News headline image
New Peer-Reviewed Publication Demonstrates Superior Weight Loss and Improved Body Composition with the Allurion Smart Capsule Combined with Lifestyle Intervention Compared to Lifestyle Intervention Alone
From Allurion Technologies, Inc.
Via Business Wire
News headline image
Allurion Announces Strategic Distribution Partnership with ProSurg Medical in Brazil to Pioneer New Approach Focused on Metabolically Healthy Weight Loss
From Allurion Technologies, Inc.
Via Business Wire
News headline image
Allurion Reports Third Quarter 2025 Financial Results and Provides Business Update
From Allurion Technologies, Inc.
Via Business Wire
News headline image
12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session ↗
Via Benzinga
News headline image
A Look at Allurion Technologies's Upcoming Earnings Report ↗
Via Benzinga
News headline image
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session ↗
Via Benzinga
News headline image
Allurion Passes Critical FDA Milestones, Enters Into Transaction to Exchange All Outstanding Debt That Would Result in the Company Being Debt-Free, and Announces a $5 Million Private Placement Financing
From Allurion Technologies, Inc.
Via Business Wire
News headline image
Allurion to Report Third Quarter 2025 Financial Results on November 12, 2025
From Allurion Technologies, Inc.
Via Business Wire
News headline image
Allurion Announces Landmark Peer-Reviewed Publication on Consecutive Use of the Allurion Smart Capsule Showing More Than 20% Weight Loss
From Allurion Technologies, Inc.
Via Business Wire
News headline image
Allurion to Participate in the ROTH 4th Annual Healthcare Opportunities Conference
From Allurion Technologies, Inc.
Via Business Wire
News headline image
12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session ↗
Via Benzinga
News headline image
12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session ↗
Via Benzinga

Frequently Asked Questions

Is Allurion Technologies, Inc. Common Stock publicly traded?
Yes, Allurion Technologies, Inc. Common Stock is publicly traded.
What exchange does Allurion Technologies, Inc. Common Stock trade on?
Allurion Technologies, Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Allurion Technologies, Inc. Common Stock?
The ticker symbol for Allurion Technologies, Inc. Common Stock is ALUR on the New York Stock Exchange
What is the current price of Allurion Technologies, Inc. Common Stock?
The current price of Allurion Technologies, Inc. Common Stock is 0.6841
When was Allurion Technologies, Inc. Common Stock last traded?
The last trade of Allurion Technologies, Inc. Common Stock was at 03/03/26 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Daily Courier, Kelowna, BC. Powered by BLOX Content Management System from TownNews.com.